Mersana Therapeutics

About:

Mersana Therapeutics develops a biodegradable polymer platform Fleximer® which creates new and better medicines.

Twitter/X: mersanaadc

Top Investors: Wellington Management, F-Prime Capital, Cormorant Asset Management, Takeda, New Enterprise Associates

Description:

Mersana Therapeutics employs its biodegradable polymer platform to create new and better medicines. They are advancing their own clinical-stage pipeline of novel compounds with the potential to address multiple oncology indications. It was founded in 2005 and headquartered in Cambridge, Massachusetts.

Total Funding Amount:

$656M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2005-01-01

Contact Email:

info(AT)mersana.com

Founders:

David R. Elmaleh